Literature DB >> 19517124

Experience with laparoscopy-assisted retroperitoneal pyeloplasty in children.

Mohan K Abraham1, Abdul Rasheed A Nasir, S Bindu, P Ramakrishnan, Prashant M Kedari, Gopidas R Unnithan, Kalyan Ravi Prasad Damisetti.   

Abstract

PURPOSE: To describe a laparoscopy-assisted retroperitoneal pyeloplasty (LARP) and results of initial experience.
METHODS: Port placement used by Farhat in retroperitoneal-assisted laparoscopic pyeloplasty was modified for better cosmetic results. Surgery was done using 2-cm incision for 5-mm camera port and two 3-mm working ports. Dissection was done anterior to the kidney. The ureteropelvic junction was brought out through the 2-cm trocar site and the pyeloplasty was performed extracorporeally. Between January 2004 and February 2008, a total of 39 kidneys in 38 children with mean age of 4.1 months underwent LARP. The operative time, hospital stay, functional outcome and follow-up renogram studies were reviewed.
RESULTS: The mean operative time was 147 min. 2-cm incision was extended in one patient with malrotated kidney. There was improvement in function in 37 (95%) with no failure. The mean split renal function, preoperative and at follow-up were 35.7 and 44.2%, respectively (P = 0.000). The mean glomerular filtration rate (ml/min), preoperative and at follow-up were 27.4 and 39.1%, respectively (P = 0.000). Mean follow-up period was 24 months.
CONCLUSION: LARP is safe in treating UPJ obstruction in infants. It is recommended especially in small babies where laparoscopic pyeloplasty is difficult.

Entities:  

Mesh:

Year:  2009        PMID: 19517124     DOI: 10.1007/s00383-009-2394-y

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  15 in total

Review 1.  Laparoscopy in urology.

Authors:  S P Hedican
Journal:  Surg Clin North Am       Date:  2000-10       Impact factor: 2.741

2.  Retroperitoneal dismembered pyeloplasty: initial experiences.

Authors:  Colin Cutting; Kirsten Borup; Neil Barber; William Choi; Ejvind U Poulsen; Johan Poulsen
Journal:  Int J Urol       Date:  2006-09       Impact factor: 3.369

3.  Retrospective comparison of retroperitoneal laparoscopic versus open dismembered pyeloplasty for ureteropelvic junction obstruction.

Authors:  Xu Zhang; Hong-Zhao Li; Xin Ma; Tao Zheng; Bin Lang; Jun Zhang; Bin Fu; Kai Xu; Xiao-Lin Guo
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

4.  Retroperitoneal-assisted laparoscopic pyeloplasty in children: initial experience.

Authors:  Walid Farhat; Kourosh Afshar; Frank Papanikolaou; Rebecca Austin; Antoine Khoury; Darius Bagli
Journal:  J Endourol       Date:  2004-11       Impact factor: 2.942

Review 5.  Extraperitoneal laparoscopic repair of ureteropelvic junction obstruction: initial experience in 15 cases.

Authors:  M R Ben Slama; L Salomon; A Hoznek; A Cicco; F Saint; W Alame; P Antiphon; D K Chopin; C C Abbou
Journal:  Urology       Date:  2000-07       Impact factor: 2.649

6.  Which is better--retroperitoneoscopic or laparoscopic dismembered pyeloplasty in children?

Authors:  Stephen J Canon; Venkata R Jayanthi; Gregory J Lowe
Journal:  J Urol       Date:  2007-08-17       Impact factor: 7.450

7.  The minimally invasive open pyeloplasty.

Authors:  Job K Chacko; Martin A Koyle; Gerald C Mingin; Peter D Furness
Journal:  J Pediatr Urol       Date:  2006-06-22       Impact factor: 1.830

8.  Laparoscopic dismembered pyeloplasty by a retroperitoneal approach in children.

Authors:  A El-Ghoneimi; W Farhat; S Bolduc; D Bagli; G McLorie; Y Aigrain; A Khoury
Journal:  BJU Int       Date:  2003-07       Impact factor: 5.588

9.  Laparoscopic pyeloplasty: a prospective randomized comparison between the transperitoneal approach and retroperitoneoscopy.

Authors:  Ahmed M Shoma; Ahmed R El Nahas; Mahmoud A Bazeed
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

Review 10.  A transperitoneal laparoscopic approach to endourology.

Authors:  A M Kaynan; H N Winfield
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.